Liothyronine Sodium
- Product NDC
- 42291-419
- 11-digit product format
- 422910419
- Labeler code
- 42291
- Product ID
- 42291-419_d57cb601-da17-2ffd-e053-2995a90a3808
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Liothyronine Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA200295
- Marketing category
- ANDA
- Marketing start
- 2018-10-11
- Marketing end
- 0000-00-00
- Substance
- LIOTHYRONINE SODIUM
- Active strength
- 50 ug/1
- Pharmacologic classes
- l-Triiodothyronine [EPC],Triiodothyronine [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42291-419-90 | 42291041990 | 90 TABLET in 1 BOTTLE (42291-419-90) | 90 tablet | 2018-10-11 | 0000-00-00 | No | No | Current |